Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06111963
Other study ID # AP2305-301-001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2023
Est. completion date August 2024

Study information

Verified date January 2024
Source National Cancer Institute, Egypt
Contact Walaa Y Elsabeeny, MD
Phone +201007798466
Email walaa.elsabeeny@nci.cu.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A diagnostic and prognostic study, in which the expression of CD64 in activated neutrophils and CD64 and IL17A regulatory T cells in patients with sepsis will be evaluated as a probable marker for sepsis as a primary objective


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date August 2024
Est. primary completion date July 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Cancer patients admitted to the surgical ICU following cancer related surgeries and diagnosed with sepsis Exclusion Criteria: - Refusal of patient or patient guardian to participate. - Intraoperative massive blood loss and massive blood transfusion - Patients with impaired preoperative kidney or liver function tests

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Serology tests
CD4, CD25, IL17

Locations

Country Name City State
Egypt Walaa Y Elsabeeny Cairo

Sponsors (1)

Lead Sponsor Collaborator
National Cancer Institute, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the expression CD4 Serology 7 days
Primary To evaluate the expression CD25 Serology 7 days
Primary To evaluate the expression IL17 Serology 7 days
See also
  Status Clinical Trial Phase
Recruiting NCT03779347 - Schistosomiasis Diagnosis Using a CAA Antigen Test Phase 3
Terminated NCT01746940 - Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia Phase 3
Not yet recruiting NCT04800042 - Study of the Prevalence of Iron Deficiency in Patients With Scheduled Major Surgery (CARENFER PBM) N/A
Completed NCT05076188 - PARamedical Abnormalties Detection of Traumatic Bone Lesion of the extremitIeS
Completed NCT03832608 - Sarcopenia Cut-points and Functionality in Older Adults
Recruiting NCT06233539 - A Study on Diagnosis and Treatment Strategies for Atlantoaxial Dislocation
Completed NCT03250884 - Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test.
Not yet recruiting NCT03495570 - Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral Infections